Pandemic Perspectives
One year on from the World Health Organization declaring COVID-19 a global pandemic, editors across our publications are taking a closer look at its impact and possible lasting implications for pharma and medtech.
One year on from the formal designation by the World Health Organization of the coronavirus outbreak as a pandemic, the disruptive effects on the global pharmaceutical supply chain, especially for the off-patent industry, are still being seen.
For years, the pharmaceuticals industry and the generics industry in particular have become increasingly reliant on supplies of ingredients and...
